QR kód

Randomized, Double-Blind, Placebo-Controlled, Multicentered Trial of the Efficacy of a Single Dose of Live Oral Cholera Vaccine CVD 103-HgR in Preventing Cholera following Challenge with Vibrio cholerae O1 El Tor Inaba Three Months after Vaccination

CVD 103-HgR is a live oral cholera vaccine strain constructed by deleting 94% of the gene for the enzymatically active A subunit of cholera toxin from classical Inaba Vibrio cholerae O1 569B; the strain also contains a mercury resistance gene as an identifying marker. This vaccine was well tolerated...

Celý popis

Uloženo v:
Vydáno v:Infect Immun
Hlavní autoři: Tacket, Carol O., Cohen, Mitchell B., Wasserman, Steven S., Losonsky, Genevieve, Livio, Sofie, Kotloff, Karen, Edelman, Robert, Kaper, James B., Cryz, Stanley J., Giannella, Ralph A., Schiff, Gilbert, Levine, Myron M.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology (ASM) 1999
Témata:
Microbial Immunity and Vaccines
On-line přístup:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC97039/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10569747/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.67.12.6341-6345.1999
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky